Patents by Inventor Tomoki Kabeya

Tomoki Kabeya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11499963
    Abstract: An object of the present invention is to provide a novel method which enables convenient preparation of cells exhibiting functions close to that of intestinal epithelial cells of living bodies, and use of the method. The differentiation of induced pluripotent stem cells into intestinal epithelial cells is induced by step of differentiating induced pluripotent stem cells into endoderm-like cells; step of differentiating the endoderm-like cells obtained in step into intestinal stem cell-like cells; and step of differentiating the intestinal stem cell-like cells obtained in step into intestinal epithelial cell-like cells, wherein step includes culture in the presence of a MEK1 inhibitor, a DNA methyltransferase inhibitor, a TGF-? receptor inhibitor, and EGF and under the condition that cAMP is supplied to the cells.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: November 15, 2022
    Assignee: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY
    Inventors: Takahiro Iwao, Tomoki Kabeya, Tamihide Matsunaga
  • Publication number: 20200370020
    Abstract: An object of the present invention is to provide a new means capable of easily and efficiently preparing cells showing a function more similar to the function of intestinal epithelial cells of a living body. According to the present invention, pluripotent stem cells are induced to differentiate into intestinal stem cell-like cells by a method for inducing differentiation of pluripotent stem cells into intestinal epithelial cells, the method including a step (1) of differentiating pluripotent stem, cells into intestinal stem cell-like cells and a step (2) of differentiating the intestinal stem cell-like cells obtained in the step (1) into intestinal epithelial cell-like cells by using an MEK1 inhibitor, a DNA methylation inhibitor, a TGF? receptor inhibitor, EGF, and a cAMP activator in combination.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Applicants: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY, FUJIFILM Corporation
    Inventors: Tamihide MATSUNAGA, Takahiro Iwao, Tomoki Kabeya, Shinji Mima, Toshihide Miyashita
  • Publication number: 20190079076
    Abstract: An object of the present invention is to provide a novel method which enables convenient preparation of cells exhibiting functions close to that of intestinal epithelial cells of living bodies, and use of the method. The differentiation of induced pluripotent stem cells into intestinal epithelial cells is induced by step of differentiating induced pluripotent stem cells into endoderm-like cells; step of differentiating the endoderm-like cells obtained in step into intestinal stem cell-like cells; and step of differentiating the intestinal stem cell-like cells obtained in step into intestinal epithelial cell-like cells, wherein step includes culture in the presence of a MEK1 inhibitor, a DNA methyltransferase inhibitor, a TGF-? receptor inhibitor, and EGF and under the condition that cAMP is supplied to the cells.
    Type: Application
    Filed: March 3, 2017
    Publication date: March 14, 2019
    Inventors: Takahiro Iwao, Tomoki Kabeya, Tamihide Matsunaga